Regeneron Pharmaceuticals
Regeneron is seeking a Regional Access Senior Manager in Spain to drive market access strategies for its oncology portfolio. The role involves building relationships with payers, leading negotiations, and collaborating with cross-functional teams to improve healthcare outcomes.
Headquarters
Tarrytown, New York, United States
Company Size
10001+ employees
Founded
1988
Discover how Regeneron (NASDAQ: REGN) harmonizes biology and technology to create life-changing medicines. Join our team and explore clinical trials.
Quadrant Capital Group LLC Purchases 1,564 Shares of Regeneron Pharmaceuticals, Inc. $REGN
4 hours ago
In 2036, Investors Will Regret Not Loading Up on This Multibagger in the Making
6 hours ago
Will Positive Obesity Data and Dupixent Expansion Efforts Change Regeneron Pharmaceuticals' (REGN) Narrative?
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Regeneron Pharmaceuticals.
Regeneron Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Regeneron: Fairly Valued Now After A Stellar Upswing (NASDAQ:REGN)
1 day ago
Associate Director, Market Access HTA, Spain
Revolution Medicines
Senior Director, Market Access, Spain
Revolution Medicines
Regional Market Access Manager
C0001163629T1
Market Access Director, Poland
Revolution Medicines
Head, Pricing and Specialty Care
AbbVie
Senior Director, Global Market Access
Cogent Biosciences